Hyperthermia-embolization-immunotherapy: a potent trio in advancing cancer treatment

Zaman R 1 , Cai X 2 , Shubhra QTH 3

Affiliations 

  • 1 School of Healthy Aging, Faculty of Medicine and Health Sciences, UCSI University, Cheras 56000, Kuala Lumpur, Malaysia
  • 2 School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou 325027, China. Electronic address: cxj520118@wmu.edu.cn
  • 3 Institute of Chemistry, University of Silesia in Katowice, 41-500 Chorzów, Poland; Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan 430060, China. Electronic address: tanminul-haque-shubra.quazi@us.edu.pl
Trends Mol Med, 2023 Dec;29(12):976-978.
PMID: 37863716 DOI: 10.1016/j.molmed.2023.10.003

Abstract

Yang et al. recently demonstrated the high potential of liquid metal microspheres (LM MSs) in cancer therapy. By amplifying the effects of magnetic hyperthermia and embolization, LM MSs not only target primary tumors, but also potentiate immune defenses. This dual-action approach effectively curtails distant tumor growth, marking a pivotal advancement in cancer immunotherapy.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications